I am a health economist, epidemiologist, and data science researcher aiming to accelerate the development of valuable drugs, vaccines, and diagnostics in the research and development pipeline to improve health.
My name is Blythe. I write and solve lots of math equations to describe how diseases progress and spread to other people. Sometimes I use those equations to simulate what would happen to people if they had used a different medicine. I consider the trade-offs of side-effects and costs alongside benefits to understand a drug’s value. My personal passion is in the development of a safe and effective HIV vaccine.
I’m senior quantitative scientist at a New York City-based startup company called Flatiron Health. The company has pioneered the curation of electronic health records, turning unstructured data (like physician notes and lab reports) into structured data for analysis. Here I have the privilege to design and lead academic research studies to learn from the experiences of more than 2 million cancer patients.
Previously, I was an HIV researcher at the NIH-funded global headquarters for the HIV Vaccine Trials Network, based at the Fred Hutchinson Cancer Research Center, for over a decade. I’ve also designed and built mathematical models of disease progression with Boston Scientific, Intellectual Ventures, the Institute for Disease Modeling, and the Patient-Centered Outcomes Research Institute (PCORI).
While an independent consultant, I generated evidence of economic value of innovative healthcare technologies for governments, non-profits, industry. I co-founded SmartDx, an award-winning diagnostic platform to support clinical decision-making with predictive patient risk factors and real-time big-data analytics.
My training as a pharmacoeconomist includes a doctorate in pharmaceutical science from The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute in the School of Pharmacy at the University of Washington, mentored by Professor Louis Garrison. Earlier in my career, I gained foundational skills in population health and study design with a masters in epidemiology from the University of Washington.
Serving as Chair of the Global ISPOR Student Network, I led more than 5,000 graduate students in 37 countries, equipped 110 presidents of university chapters, and facilitated 10 committees. We aimed to strengthen the next generation of health economists.
Learn more about
- Publications and Google Scholar Citations
- Honors and awards
- Press about my research
- Background in one-pager resume and full CV
- LinkedIn profile
- Twitter @InfectiousEcon and @DrBlytheAdamson